Press release
Global Cerebrospinal Fluid (CSF) Management Market to Reach USD 5.39 Billion by 2031, Driven by Neurosurgical Advancements and Increasing Hydrocephalus Cases
Request Sample: https://clearviewmarketinsights.com/report-details/global-cerebrospinal-fluid-management-market/
"Modern CSF management solutions are transforming the treatment landscape for hydrocephalus, traumatic brain injury, and intracranial hypertension," said Dr. Sophia Lindgren, neurodevices analyst at CVMI.
Key Market Highlights
• 2024 Market Size: USD 2.43 billion
• 2031 Forecast: USD 5.39 billion
• CAGR: 12.1% (2024-2031)
Growth Catalysts
• Surge in hydrocephalus cases: especially in aging and pediatric populations.
• Trauma and TBI Increase: Surging demand for ICP management devices.
• Technological Innovations: Programmable, antimicrobial, and AI-enabled shunt systems.
Segment Insights
• Top Product: Shunt systems hold over 65% market share.
• Fastest-Growing Segment: External drainage systems for critical care and ICP management.
• Regional leaders: North America leads, with Europe in second; Asia-Pacific is the fastest-growing.
Competitive Overview (2024)
• Medtronic - 27%: Leading with advanced programmable shunts.
• Integra - 22%: Strong portfolio in drainage systems and valves.
• B. Braun - 16%: Focused on high-performance CSF drainage.
• Others - 35%: Mix of regional players and specialized OEMs.
Outlook to 2031
The CSF management market will grow with innovations in wireless ICP monitoring, antimicrobial coatings, and AI-powered decision support. Expansion in emerging markets, along with improvements in neurosurgical care, will drive future growth.
For detailed insights or media inquiries, contact:
Clearview Market Insights - Neurological Devices Division
Bhavani K
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cerebrospinal Fluid (CSF) Management Market to Reach USD 5.39 Billion by 2031, Driven by Neurosurgical Advancements and Increasing Hydrocephalus Cases here
News-ID: 4253651 • Views: …
More Releases from ClearView Market Insights
Narcotic-Identifying Drug Devices Market to Reach USD 5.18 Billion by 2031 Amid …
[Barcelona - 24 November 2025] - Clearview Market Insights (CVMI) today announced new findings showing that the Global Narcotic-Identifying Drug Devices Market is set to expand from USD 2.06 billion in 2024 to USD 5.18 billion by 2031, representing a strong 14.1% CAGR.
The expansion reflects worldwide efforts to combat rising narcotic misuse, especially the rapid spread of synthetic opioids and designer substances.
Request Sample PDF: https://clearviewmarketinsights.com/report-details/global-narcotic-identifying-drug-devices-market/
A Global Push for Rapid, Reliable…
Global Clinical Mass Spectrometry Market to Reach USD 13.4 Billion by 2031, Driv …
[London, 22 November 2025] - Clearview Market Insights (CVMI) reports that the global clinical mass spectrometry market will grow from USD 6.2 billion in 2024 to USD 13.4 billion by 2031, with a CAGR of 11.7%. The growth is fueled by increased adoption in precision diagnostics, biomarker research, and drug monitoring.
Request Sample: https://clearviewmarketinsights.com/report-details/global-clinical-mass-spectrometry-market/
"Mass spectrometry is revolutionizing clinical testing by offering unmatched accuracy, enabling earlier disease detection and better patient…
Global Clinical Decision Support System Market to Surpass USD 21.2 Billion by 20 …
[Boston, 22 November 2025] - Clearview Market Insights (CVMI) forecasts that the global clinical decision support system market will increase from USD 8.9 billion in 2024 to USD 21.2 billion by 2031, at a compound annual growth rate (CAGR) of 13.1%. The growth is fueled by increased healthcare digitization, the adoption of EHRs, and AI-powered decision-making tools.
Request Sample: https://clearviewmarketinsights.com/report-details/global-clinical-decision-support-system-market/
"CDSS solutions are transforming patient care by enabling timely, evidence-based clinical…
Global Clamps Market to Reach USD 7.4 Billion by 2031, Driven by Industrial Grow …
[London, 6 November 2025] - Clearview Market Insights (CVMI) predicts that the global clamps market will rise from USD 5.1 billion in 2024 to USD 7.4 billion in 2031, with a CAGR of 5.4%. Growth is driven by increasing industrial activity, expansion in construction, and greater adoption in automotive and medical sectors.
"Clamps are essential tools across industries, ensuring precision, safety, and efficiency in both manufacturing and healthcare applications," said…
More Releases for CSF
G Csf And G Csf Biosimilars Market Size Trends and Forecast by Application, Type …
USA, New Jersey- According to Market Research Intellect, the global G Csf And G Csf Biosimilars market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The G-CSF and G-CSF biosimilars market is witnessing steady growth, largely due to increasing demand for affordable treatments for neutropenia, especially…
G-CSF & G-CSF Biosimilars Market Growth 2032: Increasing Cancer Treatment Demand …
The global market for Granulocyte Colony Stimulating Factor (G-CSF) and G-CSF biosimilars is on a promising growth trajectory as the demand for cost-effective and therapeutic alternatives to branded drugs increases. G-CSF and its biosimilars are vital in treating neutropenia, leukopenia, platelet disorders, and various types of cancer, and their growing adoption is fueled by technological advancements and supportive government policies.
The market size was valued at $5.89 billion USD in 2023…
G-CSF and G-CSF Biosimilars Market Size, Growth and Forecast 2021 to 2028 By Ame …
The worldwide G-CSF and G-CSF Biosimilars market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner…
G-CSF and G-CSF Biosimilars Market Size to Witness Huge Growth by 2027: Pfizer, …
G-CSF and G-CSF Biosimilars market Research Report
LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application“. This report offers an insightful take on the drivers and restraints present in the market. G-CSF and G-CSF Biosimilars data reports also provide a 5 year pre-historic and forecast…
Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novar …
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.
Request Sample Copy of Report @ https://www.researchtrades.com/request-sample/1664081
This report studies…
China CSF Management Market Outlook to 2023
New report, "China CSF Management Market Outlook to 2023", provides key market data on theChina CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Hydrocephalus Shunts and Dura Substitutes.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on…
